You just read:

AbbVie Receives CHMP Positive Opinion for Upadacitinib (RINVOQ™) for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis

News provided by

AbbVie

Oct 18, 2019, 07:30 ET